DK157482A - Galenisk praeparat indeholdende gallopamil eller verapamil og fremgangsmaade til fremstilling heraf - Google Patents

Galenisk praeparat indeholdende gallopamil eller verapamil og fremgangsmaade til fremstilling heraf Download PDF

Info

Publication number
DK157482A
DK157482A DK157482A DK157482A DK157482A DK 157482 A DK157482 A DK 157482A DK 157482 A DK157482 A DK 157482A DK 157482 A DK157482 A DK 157482A DK 157482 A DK157482 A DK 157482A
Authority
DK
Denmark
Prior art keywords
active compound
gallopamil
verapamil
procedures
preparing
Prior art date
Application number
DK157482A
Other languages
Danish (da)
English (en)
Inventor
H Einig
V Buehler
W Koch
J A Schwarz
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6129505&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK157482(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Basf Ag filed Critical Basf Ag
Publication of DK157482A publication Critical patent/DK157482A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK157482A 1981-04-07 1982-04-06 Galenisk praeparat indeholdende gallopamil eller verapamil og fremgangsmaade til fremstilling heraf DK157482A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19813113901 DE3113901A1 (de) 1981-04-07 1981-04-07 Wirkstoffzubereitung zur oralen applikation

Publications (1)

Publication Number Publication Date
DK157482A true DK157482A (da) 1982-10-08

Family

ID=6129505

Family Applications (1)

Application Number Title Priority Date Filing Date
DK157482A DK157482A (da) 1981-04-07 1982-04-06 Galenisk praeparat indeholdende gallopamil eller verapamil og fremgangsmaade til fremstilling heraf

Country Status (17)

Country Link
EP (1) EP0063266B1 (de)
JP (1) JPS57175113A (de)
AT (1) ATE14076T1 (de)
AU (1) AU555093B2 (de)
CA (1) CA1184497A (de)
DE (2) DE3113901A1 (de)
DK (1) DK157482A (de)
ES (1) ES511208A0 (de)
FI (1) FI821253L (de)
GR (1) GR74770B (de)
HU (1) HU186855B (de)
IE (1) IE52985B1 (de)
IL (1) IL65328A (de)
NO (1) NO157204C (de)
NZ (1) NZ200244A (de)
PT (1) PT74705B (de)
ZA (1) ZA822327B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4461759A (en) * 1983-01-03 1984-07-24 Verex Laboratories, Inc. Constant release rate solid oral dosage formulations of veropamil
US4874614A (en) * 1985-03-25 1989-10-17 Abbott Laboratories Pharmaceutical tableting method
US4863741A (en) * 1985-03-25 1989-09-05 Abbott Laboratories Tablet composition for drug combinations
LU86077A1 (fr) * 1985-09-18 1987-04-02 Pharlyse Sa Nouvelles formes galeniques du verapamil,leur fabrication et medicaments contenant ces nouvelles formes galeniques
LU86099A1 (fr) * 1985-09-30 1987-04-02 Pharlyse Formes galeniques a liberation prolongee du verapamil,leur fabrication et medicaments les contenant
IE58401B1 (en) * 1986-06-20 1993-09-08 Elan Corp Plc Controlled absorption pharmaceutical composition
US4981871A (en) * 1987-05-15 1991-01-01 Abelson Mark B Treatment of ocular hypertension with class I calcium channel blocking agents
US4792452A (en) * 1987-07-28 1988-12-20 E. R. Squibb & Sons, Inc. Controlled release formulation
US5230901A (en) * 1988-03-23 1993-07-27 Knoll Ag Sustained release tablet of a mixture of alginates and polyacrylates
DE3809764A1 (de) * 1988-03-23 1989-10-05 Knoll Ag Mischung aus alginaten und polyacrylaten und deren verwendung
ES2045281T3 (es) * 1988-07-13 1994-01-16 Knoll Ag Forma de medicamento de accion retardada sobre la base de alginatos.
US5032406A (en) * 1989-02-21 1991-07-16 Norwich Eaton Pharmaceuticals, Inc. Dual-action tablet
DE3932378A1 (de) * 1989-09-28 1991-04-11 Knoll Ag Feste arzneiform mit hohem verapamil-gehalt
IT1264696B1 (it) * 1993-07-09 1996-10-04 Applied Pharma Res Forme farmaceutiche destinate alla somministrazione orale in grado di rilasciare sostanze attive a velocita' controllata e differenziata
US5695781A (en) * 1995-03-01 1997-12-09 Hallmark Pharmaceuticals, Inc. Sustained release formulation containing three different types of polymers
US6083532A (en) 1995-03-01 2000-07-04 Duramed Pharmaceuticals, Inc. Sustained release formulation containing three different types of polymers and tablet formed therefrom

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1154810B (de) * 1961-04-01 1963-09-26 Knoll Ag Verfahren zur Herstellung basisch substituierter Phenylacetonitrile
DE1467781A1 (de) * 1963-07-15 1968-12-05 Boehringer Sohn Ingelheim Verfahren zur Herstellung von Dragees mit verlaengerter Wirkstofffreigabe

Also Published As

Publication number Publication date
AU555093B2 (en) 1986-09-11
AU8238482A (en) 1982-10-14
NO157204C (no) 1988-02-10
JPS57175113A (en) 1982-10-28
NZ200244A (en) 1984-08-24
FI821253L (fi) 1982-10-08
DE3264519D1 (en) 1985-08-08
IE52985B1 (en) 1988-04-27
CA1184497A (en) 1985-03-26
ATE14076T1 (de) 1985-07-15
IL65328A0 (en) 1982-05-31
ES8307496A1 (es) 1983-08-16
IE820812L (en) 1982-10-07
HU186855B (en) 1985-10-28
EP0063266A2 (de) 1982-10-27
ES511208A0 (es) 1983-08-16
PT74705A (en) 1982-05-01
EP0063266B1 (de) 1985-07-03
ZA822327B (en) 1983-03-30
GR74770B (de) 1984-07-12
IL65328A (en) 1985-06-30
NO157204B (no) 1987-11-02
NO821084L (no) 1982-10-08
PT74705B (en) 1983-11-14
FI821253A0 (fi) 1982-04-07
DE3113901A1 (de) 1982-10-28
EP0063266A3 (en) 1983-05-04

Similar Documents

Publication Publication Date Title
DK157482A (da) Galenisk praeparat indeholdende gallopamil eller verapamil og fremgangsmaade til fremstilling heraf
NO171365C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
DE59102210D1 (de) Galanthemin enthaltende pharmazeutische Formulierung zur Behandlung des Alkoholismus.
ES2171469T3 (es) Composicion administrada por via nasal y preparacion que la contiene.
FR2694004B1 (fr) Nouvelles 3-(Hydroxybenzylidényl)-indoline-2-ones et 3-(hydroxybenzylidényl)-indoline-2-thiones, leurs procédés de préparation, et les compositions pharmaceutiques qui les contiennent.
ATE16191T1 (de) Stabile salze von s-adenosinylmethionin, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen welche als aktive substanz diese derivate enthalten.
SE8404065D0 (sv) Novel biologically active compounds
ES2051834T3 (es) El uso de tetrahidrobenzeno(c,d)indol-6 carboxamidas para la preparacion de un medicamento para el tratamiento de la ansiedad.
KR830002510A (ko) 생물학적 활성화합물과 하이드록시알킬 전분으로 구성되는 조성물
HK134494A (en) Substituted release azelastine containing medicaments
SE8600658D0 (sv) Novel composition of matter
KR890004705A (ko) 항바이러스성 제제
ATE13488T1 (de) Gallium-chlorid, ein neues antikrebsmittel.
ATE18203T1 (de) (-)-15-deoxyspergualin, seine herstellung und arzneimittel mit diesem wirkstoff.
KR880004810A (ko) 소화성 궤양 치료제
PH25715A (en) Cyclic growth hormone releasing factor analogs, pharmaceutical composition containing said compound , process for the preparation thereof
KR910018026A (ko) α-페닐-α피리딜알칸산 유도체를 함유하는 배뇨장애증상 치료제
KR890007737A (ko) 진토작용을 하는 약제
IL87867A (en) Preparation of pharmaceutical compositions containing a 2,6-diamino-3-phenyl-azo-pyridine derivative
KR890002058A (ko) 간질 및 불안 상태의 예방 및 치료용 2,4,6-트리스-3-급-부틸아미노-1,-3,-5-트리아진
SE8304818L (sv) Medicin med magsarslekande, spasmolytisk och lokalanesteserande verkan
TH3319EX (th) กรรมวิธีสำหรับการเตรียม n-(2-พิริติล)-2-เมทธิล-4-ไฮดรอกซี-2h-1,2-เบนโซไทอะซิน-3-คาร์บอกซะไมด์-1,1ไดออกไซด์
TH6256EX (th) อนุพันธ์ แอริล สารต่อต้านการอักเสบ

Legal Events

Date Code Title Description
PBP Patent lapsed
AHS Application shelved for other reasons than non-payment